Korbecki J, Bosiacki M, Stasiak P, Snarski E, Brodowska A, Chlubek D
Cancers (Basel). 2024; 16(19).
PMID: 39409868
PMC: 11476337.
DOI: 10.3390/cancers16193246.
Huang C, Liu Q, Zheng S, Liu T, Tan Y, Peng T
Dig Dis Sci. 2024; 69(5):1562-1570.
PMID: 38580886
PMC: 11098888.
DOI: 10.1007/s10620-024-08392-y.
Li R, Huang B, Tian H, Sun Z
Front Oncol. 2023; 12:1096717.
PMID: 36698392
PMC: 9868934.
DOI: 10.3389/fonc.2022.1096717.
Zheng S, Liu B, Guan X
Front Oncol. 2022; 12:911285.
PMID: 35814365
PMC: 9257257.
DOI: 10.3389/fonc.2022.911285.
Matsuo K, Yoshie O, Nakayama T
Cancers (Basel). 2021; 13(23).
PMID: 34885241
PMC: 8656932.
DOI: 10.3390/cancers13236132.
Relationship between Th17 immune response and cancer.
Marques H, de Brito B, da Silva F, Santos M, de Souza J, Correia T
World J Clin Oncol. 2021; 12(10):845-867.
PMID: 34733609
PMC: 8546660.
DOI: 10.5306/wjco.v12.i10.845.
Bladder tumor ILC1s undergo Th17-like differentiation in human bladder cancer.
Mukherjee N, Ji N, Tan X, Lin C, Rios E, Chen C
Cancer Med. 2021; 10(20):7101-7110.
PMID: 34496133
PMC: 8525153.
DOI: 10.1002/cam4.4243.
Recruitment and Expansion of Tregs Cells in the Tumor Environment-How to Target Them?.
Cinier J, Hubert M, Besson L, Di Roio A, Rodriguez C, Lombardi V
Cancers (Basel). 2021; 13(8).
PMID: 33924428
PMC: 8069615.
DOI: 10.3390/cancers13081850.
The Protein Secretome Is Altered in Rectal Cancer Tissue Compared to Normal Rectal Tissue, and Alterations in the Secretome Induce Enhanced Innate Immune Responses.
Heeran A, Dunne M, Morrissey M, Buckley C, Clarke N, Cannon A
Cancers (Basel). 2021; 13(3).
PMID: 33540635
PMC: 7867296.
DOI: 10.3390/cancers13030571.
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4.
Korbecki J, Kojder K, Siminska D, Bohatyrewicz R, Gutowska I, Chlubek D
Int J Mol Sci. 2020; 21(21).
PMID: 33182504
PMC: 7665155.
DOI: 10.3390/ijms21218412.
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands.
Korbecki J, Grochans S, Gutowska I, Barczak K, Baranowska-Bosiacka I
Int J Mol Sci. 2020; 21(20).
PMID: 33076281
PMC: 7590012.
DOI: 10.3390/ijms21207619.
Hypoxia Alters the Expression of CC Chemokines and CC Chemokine Receptors in a Tumor-A Literature Review.
Korbecki J, Kojder K, Barczak K, Siminska D, Gutowska I, Chlubek D
Int J Mol Sci. 2020; 21(16).
PMID: 32781743
PMC: 7460668.
DOI: 10.3390/ijms21165647.
Esophageal Microenvironment: From Precursor Microenvironment to Premetastatic Niche.
Han P, Cao P, Hu S, Kong K, Deng Y, Zhao B
Cancer Manag Res. 2020; 12:5857-5879.
PMID: 32765088
PMC: 7371556.
DOI: 10.2147/CMAR.S258215.
The CCL20-CCR6 Axis in Cancer Progression.
Kadomoto S, Izumi K, Mizokami A
Int J Mol Sci. 2020; 21(15).
PMID: 32707869
PMC: 7432448.
DOI: 10.3390/ijms21155186.
IL-17-Producing Cells in Tumor Immunity: Friends or Foes?.
Kuen D, Kim B, Chung Y
Immune Netw. 2020; 20(1):e6.
PMID: 32158594
PMC: 7049578.
DOI: 10.4110/in.2020.20.e6.
The Fate of Th17 Cells is Shaped by Epigenetic Modifications and Remodeled by the Tumor Microenvironment.
Renaude E, Kroemer M, Loyon R, Binda D, Borg C, Guittaut M
Int J Mol Sci. 2020; 21(5).
PMID: 32121394
PMC: 7084267.
DOI: 10.3390/ijms21051673.
Dysregulation of helper T lymphocytes in esophageal squamous cell carcinoma (ESCC) patients is highly associated with aberrant production of miR-21.
Samiei H, Sadighi-Moghaddam B, Mohammadi S, Gharavi A, Abdolmaleki S, Khosravi A
Immunol Res. 2019; 67(2-3):212-222.
PMID: 31278653
DOI: 10.1007/s12026-019-09079-7.
A nutrigenetic approach for investigating the chemopreventive effects of black raspberries during the development of preneoplastic esophagi in rats.
Pan P, Dombkowski A, Wang L, Stoner G
J Berry Res. 2019; 8(4):263-274.
PMID: 30613310
PMC: 6319902.
DOI: 10.3233/JBR-180346.
Expression of CCR6 in esophageal squamous cell carcinoma and its effects on epithelial-to-mesenchymal transition.
Liu J, Zheng X, Deng H, Xu B, Chen L, Wang Q
Oncotarget. 2018; 8(70):115244-115253.
PMID: 29383156
PMC: 5777768.
DOI: 10.18632/oncotarget.23318.
Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview.
Frick V, Rubie C, Keilholz U, Ghadjar P
World J Gastroenterol. 2016; 22(2):833-41.
PMID: 26811629
PMC: 4716081.
DOI: 10.3748/wjg.v22.i2.833.